trial,pubID,pseudogroup,weeks,group,IgD-/IgM-/IgA-/IgG+/Antigen++ B cells
G002,G002-577,G002,-5,2,19.0
G002,G002-302,G002,-5,1,15.0
G002,G002-341,G002,-5,2,8.0
G002,G002-997,G002,-5,3,26.0
G002,G002-931,G002,-5,3,22.0
G002,G002-855,G002,-5,2,25.0
G002,G002-427,G002,-5,3,33.0
G002,G002-293,G002,-5,2,45.0
G002,G002-304,G002,-5,3,2.0
G002,G002-502,G002,-5,1,22.0
G002,G002-595,G002,-5,3,47.0
G002,G002-516,G002,-5,1,36.0
G002,G002-689,G002,-5,3,7.0
G002,G002-371,G002,-5,3,31.0
G002,G002-632,G002,-5,3,23.0
G002,G002-619,G002,-5,1,6.0
G002,G002-630,G002,-5,2,97.0
G002,G002-136,G002,-5,2,38.0
G002,G002-145,G002,-5,2,35.0
G002,G002-852,G002,-5,1,79.0
G002,G002-477,G002,-5,3,46.0
G002,G002-884,G002,-5,3,52.0
G002,G002-462,G002,-5,3,19.0
G002,G002-810,G002,-5,3,35.0
G002,G002-866,G002,-5,3,53.0
G002,G002-678,G002,-5,1,9.0
G002,G002-871,G002,-5,3,15.0
G002,G002-831,G002,-5,2,15.0
G002,G002-620,G002,-5,2,13.0
G002,G002-834,G002,-5,1,7.0
G002,G002-733,G002,-5,1,31.0
G002,G002-825,G002,-5,3,13.0
G002,G002-480,G002,-5,2,19.0
G002,G002-813,G002,-5,1,31.0
G002,G002-616,G002,-5,1,24.0
G002,G002-969,G002,-5,1,26.0
G002,G002-509,G002,-5,1,25.0
G002,G002-957,G002,-5,2,27.0
G002,G002-254,G002,-5,1,42.0
G002,G002-493,G002,-5,2,3.0
G002,G002-943,G002,-5,2,33.0
G002,G002-820,G002,-5,2,77.0
G002,G002-905,G002,-5,1,9.0
G002,G002-278,G002,-5,3,15.0
G002,G002-758,G002,-5,1,26.0
G002,G002-796,G002,-5,3,14.0
G002,G002-479,G002,-5,1,21.0
G002,G002-546,G002,-5,1,17.0
G002,G002-119,G002,-5,2,12.0
G002,G002-230,G002,-5,2,31.0
G002,G002-947,G002,-5,2,25.0
G002,G002-988,G002,-5,3,41.0
